Interview: EMA’s Peter Arlett reflects on RWE approvals, early learnings from DARWIN
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesClinical TrialsEuropePharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development